{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:54:36Z","timestamp":1780487676428,"version":"3.54.1"},"reference-count":71,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Antimicrobial (AMR) and antibiotic resistance (AR) remain major growing issues around the world. According to WHO, vaccinations play a strategic role in tackling AMR\/AR; the new (upcoming) or existing vaccines (both viral and bacterial) directed toward resistant pathogens, may consistently reduce the overall burden of infectious diseases across the population. The objective of the present work is to review the available evidence on the impact that immunization schedules might exert in terms of antibiotic use reduction, focusing on vaccinations included in the Italian National Immunization Plan (NIP). Methods: A targeted literature search, limited to 2015\u20132025, was performed in the PubMed database to identify the available evidence on the impact that vaccinations exert on antibiotic use or reduction. Results: The search provided evidence on the potential impact that immunizations included in the NIP might exert in tackling AMR\/AR. Influenza and pneumococcal vaccinations proved to be those with the broadest base of evidence in reducing antibiotic prescriptions. Preliminary local evidence also suggests an impact on reducing antibiotic use for RSV immunization among adults and older adults. Rotavirus vaccination proved to reduce antibiotic prescriptions, while varicella disease was associated with a relevant use of antibiotics. Conclusions: Vaccines are essential in the fight against AMR\/AR. In this review the evidence on the impact that vaccinations included in the NIP may exert was compacted. The impact of vaccines on reducing AMR\/AR should be recognized by Italian stakeholders and strategies and implementation plans should always include vaccines as interventions to reduce AMR\/AR.<\/jats:p>","DOI":"10.3390\/vaccines13111141","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:09:47Z","timestamp":1762358987000},"page":"1141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccinations Included in the National Immunization Calendar as a Tool to Tackle Antimicrobial Resistance: Current Evidence for Selected Pathogens in Italy"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-4828","authenticated-orcid":false,"given":"Giulia Carla","family":"Marchetti","sequence":"first","affiliation":[{"name":"Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, ASST Santi Paolo e Carlo, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-4828","authenticated-orcid":false,"given":"Paolo Giuseppino","family":"Castiglia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Italian Scientific Society of Hygiene, Preventive Medicine and Public Health (SItI), 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-9579","authenticated-orcid":false,"given":"Andrea","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-8990","authenticated-orcid":false,"given":"Federico","family":"Marchetti","sequence":"additional","affiliation":[{"name":"GSK Vaccines, 37135 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-4923","authenticated-orcid":false,"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[{"name":"Italian Scientific Society of Hygiene, Preventive Medicine and Public Health (SItI), Cogorno (Ge), Adult Immunization Board (AIB), 16030 Cogorno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"ref_1","unstructured":"WHO Antimicrobial Resistance (2025, September 25). Key Facts. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.24976\/Discov.Med.202335178.70","article-title":"Therapeutic and Unconventional Strategies to Contrast Antimicrobial Resistance: A Literature Review","volume":"35","author":"Vitiello","year":"2023","journal-title":"Discov. Med."},{"key":"ref_3","unstructured":"Jonas, O.B., Irwin, A., Berthe, F.C.J., Le Gall, F.G., and Marquez, P.V. (2017). Drug-Resistant Infections: A Threat to Our Economic Future (Vol. 2 of 2): Final Report, World Bank Group. Available online: http:\/\/documents.worldbank.org\/curated\/en\/323311493396993758."},{"key":"ref_4","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_5","unstructured":"WHO Global Research Agenda for Antimicrobial Resistance in Human Health (2025, September 25). Policy Brief. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/antimicrobial-resistance\/amr-spc-npm\/who-global-research-agenda-for-amr-in-human-health---policy-brief.pdf?sfvrsn=f86aa073_4&download=true."},{"key":"ref_6","unstructured":"(2025, September 25). ECDC 2024: European Antibiotic Awareness Day 2024: Key messages. Available online: https:\/\/antibiotic.ecdc.europa.eu\/en\/european-antibiotic-awareness-day-2024-key-messages."},{"key":"ref_7","unstructured":"(2025, September 25). WHO Antibiotics Most Responsible for Drug Resistance Are Overused\u2014WHO Report. Available online: https:\/\/www.who.int\/news\/item\/29-04-2025-antibiotics-most-responsible-for-drug-resistance-are-overused---who-report."},{"key":"ref_8","unstructured":"WHO (2022). The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240062382."},{"key":"ref_9","unstructured":"(2025, September 25). WHO Global Action Plan on Antimicrobial Resistance. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/193736\/9789241509763_eng.pdf?sequence=1."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1011","DOI":"10.1093\/cid\/ciab062","article-title":"Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework","volume":"73","author":"Vekemans","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","unstructured":"WHO (2023). People-Centered Approach to Addressing Antimicrobial Resistance in Human Health: WHO Core Package of Interventions to Support National Action Plans, World Health Organization."},{"key":"ref_12","unstructured":"FAO, UNEP, WHO, and WOAH (2025, September 25). One Health Joint Plan of Action (2022\u20132026). Working Together for the Health of Humans, Animals, Plants and the Environment. Rome. Available online: https:\/\/openknowledge.fao.org\/server\/api\/core\/bitstreams\/fc522db2-9619-4f70-b6ba-64177f4865e6\/content."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107188","DOI":"10.1016\/j.phrs.2024.107188","article-title":"Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017\u20132023: Opportunities and gaps","volume":"204","author":"Sabbatucci","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_14","unstructured":"WHO European Region (2025, September 25). Roadmap on Antimicrobial Resistance for the WHO European Region 2023\u20132030. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/372503\/73wd07e-AMR-Roadmap-230574.pdf?sequence=5."},{"key":"ref_15","unstructured":"AIFA Osservatorio Nazionale sull\u2019impiego dei Medicinali (2025). L\u2019uso degli antibiotici in Italia. Rapporto Nazionale 2023."},{"key":"ref_16","unstructured":"Iacchini, S., Boros, S., Pezzotti, P., Errico, G., Del Grosso, M., Camilli, R., Giufr\u00e8, M., Pantosti, A., Maraglino, F., and Palamara, A.T. (2024). AR-ISS: Sorveglianza nazionale dell\u2019Antibiotico-Resistenza. Dati 2023, Rapporti ISS Sorveglianza RIS-5\/2024, Istituto Superiore di Sanit\u00e0."},{"key":"ref_17","unstructured":"Ministero della Salute (2025, September 25). Piano Nazionale di Contrasto all\u2019Antibiotico-Resistenza (PNCAR) 2022\u20132025, Available online: https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3294_allegato.pdf."},{"key":"ref_18","unstructured":"Ministero della Salute (2025, September 25). Intesa ai Sensi Dell\u2019articolo, 8.; Comma, 6.; Della Legge 5 Giugno, 2.0.0.3.; n, 1.3.1.; trai l Governo le Regioni e le Province Autonome di Trento e di Bolzano sul Documento Recante <<Piano Nazionale di Prevenzione Vaccinale (PNPV) 2023\u20132025>> e sul Documento Recante <<Calendario Nazionale Vaccinale>> (Rep atti n 193\/CSRdel 2 agosto 2023) (23A04685), (.G.U. Serie Generale, n. 194 del 21 Agosto 2023), Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=95963&completo=true."},{"key":"ref_19","first-page":"22","article-title":"Raccomandazioni per una strategia efficace contro la resistenza antimicrobica. Dalla prevenzione vaccinale allo sviluppo e utilizzo dei nuovi antibiotici","volume":"29","year":"2022","journal-title":"Rivista SIMG"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Costanzo, V., and Roviello, G.N. (2023). The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines, 11.","DOI":"10.3390\/vaccines11020333"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Iwu-Jaja, C., Gahimbare, L., Mazingisa, A.V., Fuller, W., Mazengiya, D.Y., Okeibunor, J., Olu, O.O., Katoto, P.M.C., Yahaya, A.A., and Nyarko, K. (2025). Mapping the role of vaccines in combating AMR in the WHO African region: A scoping review and implications for research and policy. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11080-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: An analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_23","unstructured":"WHO (2024). Estimating the Impact of Vaccines in Reducing Antimicrobial Resistance and Antibiotic Use: Technical Report, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/379116\/9789240098787-eng.pdf?sequence=1."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2228669","DOI":"10.1080\/21645515.2023.2228669","article-title":"Challenges in development of vaccines directed toward antimicrobial resistant bacterial species","volume":"19","author":"Brazzoli","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0140-6736(24)00878-X","article-title":"Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance","volume":"403","author":"Laxminarayan","year":"2024","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2215149","DOI":"10.1080\/21645515.2023.2215149","article-title":"Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance","volume":"19","author":"Yemeke","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_27","unstructured":"(2025, September 25). Calendario Vaccinale per la Vita, 5 Edizione 2025. Available online: https:\/\/www.igienistionline.it\/docs\/2024\/19cdv.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.00133510","article-title":"CAPNETZStudy Group Influenza vaccination is associated with reduced severity of community-acquired pneumonia","volume":"38","author":"Tessmer","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rates in Hutterite communities: A randomized trial","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wang, B., Russell, M.L., Moss, L., Fonseca, K., Earn, D.J.D., Aoki, F., Horsman, G., Van Caeseele, P., Chokani, K., and Vooght, M. (2016). Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167281"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Barchitta, M., Maugeri, A., Vinci, R., and Agodi, A. (2022). The Inverse Relationship between Influenza Vaccination and Antimicrobial Resistance: An Ecological Analysis of Italian Data. Vaccines, 10.","DOI":"10.3390\/vaccines10040554"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cmi.2019.06.030","article-title":"Impact of vaccination on antibiotic usage: A systematic review and meta-analysis","volume":"25","author":"Buckley","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13756-023-01272-6","article-title":"The impact of influenza and pneumococcal vaccination on antibiotic use: An updated systematic review and meta-analysis","volume":"12","author":"Paget","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e011341","DOI":"10.1136\/bmjgh-2022-011341","article-title":"Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: Modelling study","volume":"8","author":"Kim","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1900233","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233","article-title":"Burden of varicella complications in secondary care, England, 2004 to 2017","volume":"24","author":"Bernal","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vandenhaute, J., Tsakeu, E., Chevalier, P., Pawaskar, M., Ben\u010dina, G., and Vertriest, J. (2021). Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06848-4"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pawaskar, M., Fergie, J., Harley, C., Samant, S., Veeranki, P., Diaz, O., and Conway, J.H. (2015). Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269916"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Barbieri, E., Cocchio, S., Furlan, P., Scamarcia, P., Cantarutti, L., Giaquinto, C., and Baldo, V. (2025). A population database analysis to describe the residual burden of varicella in Italy-a high vaccination coverage area-from 2004 to 2022. Front. Public Health, 3.","DOI":"10.3389\/fpubh.2025.1412620"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S1473-3099(23)00568-6","article-title":"The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: Effects beyond prevention of acute respiratory illness","volume":"24","author":"Feikin","year":"2024","journal-title":"Rev. Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/jac\/dkaf043","article-title":"General practice antibiotic prescriptions attributable to respiratory syncytial virus by age and antibiotic class: An ecological analysis of the English population","volume":"80","author":"Miller","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Puggina, A., Dovizio, M., Domnich, A., Marijam, A., Veronesi, C., Rizzo, C., Vicentini, M., Degli Esposti, L., Calabr\u00f2, G.E., and Fonseca, M.J. (2025). Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged \u2265 60 Years: A Retrospective Cohort Study. Diseases, 13.","DOI":"10.3390\/diseases13030068"},{"key":"ref_44","unstructured":"Puggina, A., Fonseca, M.J., Nugnes, M., Domnich, A., Veronesi, C., Rizzo, C., Vicentini, M., Degli Esposti, L., Calabr\u00f2, G.E., and Marchetti, F. (2025, January 22\u201325). Pattern of antibiotic prescriptions in adult patients hospitalized with respiratory syncytial virus in Italy. Proceedings of the 58th National Congress of the Italian Society of Public Health and Preventive Medicine, Bologna, Italy. Abstract code SIT22612-93."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Puggina, A., Rumi, F., Zarkadoulas, E., Marijam, A., and Calabr\u00f3, G.E. (2025). The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy. Vaccines, 13.","DOI":"10.3390\/vaccines13030212"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"ofac276","DOI":"10.1093\/ofid\/ofac276","article-title":"Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007\u20132018","volume":"9","author":"Hall","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Isonne, C., Petrone, D., Del Manso, M., Iera, J., Caramia, A., Bandini, L., Fadda, G., Grossi, A., Baccolini, V., and Costantino, C. (2023). The Impact of Rotavirus Vaccination on Discharges for Pediatric Gastroenteritis in Italy: An Eleven Year (2009\u20132019) Nationwide Analysis. Vaccines, 11.","DOI":"10.3390\/vaccines11061037"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2014-4015","article-title":"First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak","volume":"135","author":"McNamara","year":"2015","journal-title":"Pediatrics"},{"key":"ref_50","unstructured":"Istituto Superiore di Sanit\u00e0 (2021). Sorveglianza Nazionale Delle Malattie Batteriche Invasive. Dati 2021\u20132023, Istituto Superiore di Sanit\u00e0. Rapporti ISS Sorveglianza RIS-2\/2024."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2329678","DOI":"10.1001\/jamanetworkopen.2023.29678","article-title":"Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy","volume":"6","author":"Lodi","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/jiae383","article-title":"Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis","volume":"231","author":"Abara","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_53","unstructured":"UK Health Security Agency (2025, September 25). A Guide to the Meningococcal B Vaccine for Protection Against Gonorrhoea. Guidance Updated 28 July 2025, Available online: https:\/\/www.gov.uk\/government\/publications\/meningococcal-b-menb-vaccination-against-gonorrhoea-guide\/a-guide-to-the-meningococcal-b-vaccine-for-protection-against-gonorrhoea."},{"key":"ref_54","unstructured":"Istituto Superiore di Sanit\u00e0 (2025). Notiziario ISS, Istituto Superiore di Sanit\u00e0. Numero 7-8 Luglio-Agosto."},{"key":"ref_55","unstructured":"European Centre for Disease Prevention and Control (2024). Gonococcal Antimicrobial Susceptibility Surveillance in the European Union\/European Economic Area, 2022, ECDC."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","article-title":"Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2352-4642(21)00335-7","article-title":"Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: A national surveillance and modelling study","volume":"6","author":"Campbell","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_58","unstructured":"(2025, September 25). Pertussis Annual Epidemiological Report for 2022, E.-C.D.C.. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/PERT_AER_2022_Report.pdf."},{"key":"ref_59","unstructured":"World Health Organization (2015). Pertussis Vaccines: WHO Position Paper\u2014August 2015 Weekly Epidemiological Record, World Health Organization."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Tozzi, A., Croci, I., Gesualdo, F., Perno, C.F., Linardos, G., Villani, A., Russo, L., Campagna, I., Ferro, D., and Pandolfi, E. (2025). Effect of Early Administration of Clarithromycin or Azithromycin on Symptoms of Pertussis in Infants. Antibiotics, 14.","DOI":"10.3390\/antibiotics14030279"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2151291","DOI":"10.1080\/21645515.2022.2151291","article-title":"Available evidence and potential for vaccines for reduction in antibiotic prescriptions","volume":"18","author":"Gabutti","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bagordo, F., Grassi, T., Savio, M., Rota, M.C., Baldovin, T., Vicentini, C., Napolitano, F., Trombetta, C.M., and Gabutti, G. (2023). Seroepidemiological Study Group Assessment of Pertussis Underreporting in Italy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051732"},{"key":"ref_63","unstructured":"(2025, September 25). Morbillo e Rosolia News, Rapporto n.37, Gennaio 2018. Available online: www.epicentro.iss.it\/morbillo\/bollettino\/RM_News_2018_37%20def.pdf."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Filia, A., Del Manso, M., Petrone, D., Magurano, F., Gioacchini, S., Pezzotti, P., Palamara, A.T., and Bella, A. (2025). Surge in Measles Cases in Italy from August 2023 to January 2025: Characteristics of Cases and Public Health Relevance. Vaccines, 13.","DOI":"10.3390\/vaccines13070663"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40121-024-01002-4","article-title":"The Incidence of Herpes Zoster Complications: A Systematic Literature Review","volume":"13","author":"Giannelos","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_66","unstructured":"(2025, September 25). Rapporto Epidemiologico RespiVirNet Rapporto, N. 25 del 5 Maggio 2025. Available online: https:\/\/respivirnet.iss.it\/pagine\/rapportoInflunet.aspx."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Dougan, G., and Hugo-Webb, E. (2025). Impact of vaccines on antimicrobial resistance. J. Med. Microbiol., 74.","DOI":"10.1099\/jmm.0.002050"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.327.7429.1459","article-title":"Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials","volume":"327","author":"Smith","year":"2003","journal-title":"BMJ"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"k5094","DOI":"10.1136\/bmj.k5094","article-title":"Parachute use to prevent death and major trauma when jumping from aircraft: Randomized controlled trial","volume":"363","author":"Yeh","year":"2018","journal-title":"BMJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1200\/OP-24-00935","article-title":"How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View","volume":"21","author":"Lasagna","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1080\/21645515.2021.1969853","article-title":"Survey among Italian experts on existing vaccines\u2019 role in limiting antibiotic resistance","volume":"17","author":"Marchetti","year":"2021","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/11\/1141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:16:05Z","timestamp":1762492565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/11\/1141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["vaccines13111141"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13111141","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}